Related Articles for PubMed (Select 16984627)

Tuberculosis chemotherapy: current drug delivery approaches.

du Toit LC, Pillay V, Danckwerts MP.

Respir Res. 2006 Sep 19;7(1):118. Review.

PMID: 16984627 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

[Development of antituberculous drugs: current status and future prospects]

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID: 17240921 [PubMed - indexed for MEDLINE]

[Tuberculosis-current therapeutic principles]

Greinert U, Zabel P.

Internist (Berl). 2003 Nov;44(11):1394-405. Review. German.

PMID: 14689075 [PubMed - indexed for MEDLINE]

The magic bullets and tuberculosis drug targets.

Zhang Y.

Annu Rev Pharmacol Toxicol. 2005;45:529-64. Review.

PMID: 15822188 [PubMed - indexed for MEDLINE]

The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

Gelperina S, Kisich K, Iseman MD, Heifets L.

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1487-90. Epub 2005 Sep 8. Review.

PMID: 16151040 [PubMed - indexed for MEDLINE]

Tuberculosis drug targets.

Zhang Y, Amzel LM.

Curr Drug Targets. 2002 Apr;3(2):131-54. Review.

PMID: 11958297 [PubMed - indexed for MEDLINE]

The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis.

Blomberg B, Spinaci S, Fourie B, Laing R.

Bull World Health Organ. 2001;79(1):61-8. Epub 2003 Nov 5.

PMID: 11217670 [PubMed - indexed for MEDLINE]

Pharmacokinetic factors in the modern drug treatment of tuberculosis.

Douglas JG, McLeod MJ.

Clin Pharmacokinet. 1999 Aug;37(2):127-46. Review.

PMID: 10496301 [PubMed - indexed for MEDLINE]

[Anti-tuberculosis chemotherapy]

Wada M.

Kekkaku. 2007 Oct;82(10):771-81. Review. Japanese.

PMID: 18018601 [PubMed - indexed for MEDLINE]

10:

Implementation of fixed-dose combinations in tuberculosis control: outline of responsibilities.

Chaulet P.

Int J Tuberc Lung Dis. 1999 Nov;3(11 Suppl 3):S353-7; discussion S381-7.

PMID: 10593717 [PubMed - indexed for MEDLINE]

11:

Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis.

Pandey R, Khuller GK.

Tuberculosis (Edinb). 2005 Jul;85(4):227-34.

PMID: 15922668 [PubMed - indexed for MEDLINE]

12:

[Treatment of tuberculosis infection]

Billy C, Perronne C.

Ann Med Interne (Paris). 2002 Mar;153(2):119-27. Review. French.

PMID: 12037494 [PubMed - indexed for MEDLINE]

13:

Advances in molecular targets and chemotherapy of tuberculosis.

Kumari S, Ram VJ.

Drugs Today (Barc). 2004 Jun;40(6):487-500. Review.

PMID: 15349129 [PubMed - indexed for MEDLINE]

14:

Oral solid lipid nanoparticle-based antitubercular chemotherapy.

Pandey R, Sharma S, Khuller GK.

Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):415-20. Epub 2005 Oct 26.

PMID: 16256437 [PubMed - indexed for MEDLINE]

15:

Nanotechnology based drug delivery system(s) for the management of tuberculosis.

Pandey R, Khuller GK.

Indian J Exp Biol. 2006 May;44(5):357-66. Review.

PMID: 16708887 [PubMed - indexed for MEDLINE]

16:

Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.

Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Sateesh K, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P, Moore T.

Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):703-21. Review.

PMID: 15632956 [PubMed - indexed for MEDLINE]

17:

Formulation and statistical optimization of a novel crosslinked polymeric anti-tuberculosis drug delivery system.

du Toit LC, Pillay V, Danckwerts MP, Penny C.

J Pharm Sci. 2008 Jun;97(6):2176-207.

PMID: 17879985 [PubMed - indexed for MEDLINE]

18:

Antituberculosis drug resistance: practical solutions to practical problems.

Tayler E.

J Med Microbiol. 1997 Jul;46(7):531-3. No abstract available.

PMID: 9236735 [PubMed - indexed for MEDLINE]

19:

Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.

Ribera E, Azuaje C, Lopez RM, Domingo P, Curran A, Feijoo M, Pou L, Sánchez P, Sambeat MA, Colomer J, Lopez-Colomes JL, Crespo M, Falcó V, Ocaña I, Pahissa A.

J Antimicrob Chemother. 2007 Apr;59(4):690-7. Epub 2007 Feb 16.

PMID: 17307771 [PubMed - indexed for MEDLINE]

20:

Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential.

Ahmad Z, Pandey R, Sharma S, Khuller GK.

Indian J Chest Dis Allied Sci. 2006 Jul-Sep;48(3):171-6.

PMID: 18610673 [PubMed - indexed for MEDLINE]

Recent Activity